About Helixis
Helixis is a company based in Carlsbad (United States) founded in 2007 was acquired by Illumina in July 2010. Helixis has raised $17.33 million across 2 funding rounds from investors including Illumina, Domain Associates and Okapi Venture Capital. Helixis operates in a competitive market with competitors including Cepheid, Fluidigm, Complete Genomics, GenapSys and Stilla Technologies, among others.
- Headquarter Carlsbad, United States
- SectorsHealthcare
- Website helixis.com
- Social X
- Acquired by Illumina (Jul 2010)
Funding Insights of Helixis
Helixis has successfully raised a total of $17.33M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $7.33 million completed in October 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17.33M
- Total Rounds 2
- Last Round Series A — $7.33M
- First Round $10M
(Aug 2007)
- Investors Count 3
All 2 funding rounds of Helixis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2009 | $7.33M | Series A | – | – | – |
| Aug 2007 | $10M | Series A | – | – |
4 investors in total: 4 institutional.
Investors in Helixis
Helixis has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Illumina, Domain Associates and Okapi Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life science & tech focused VC firm investing in the US | – | domainvc.com | Princeton, United States | |
US focused VC investment company | – | okapivc.com | Newport Beach, United States | |
VC firm making investment in early stage startups in the US | – | atvcapital.com | Menlo Park, United States | |
Developer of technologies for analysis of genetic variation and function | 1993 | illumina.com | San Diego, United States |
Investor details for Helixis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Helixis
4 dated milestones of Helixis across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Helixis is founded.
- Funding First funding round of $10.0M.
- Funding Latest funding round, Series A, of $7.3M.
- Exit Acquired by Illumina.
Competitors of Helixis
Helixis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Fluidigm, Complete Genomics, GenapSys and Stilla Technologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cepheid.com | 1996 | Sunnyvale, United States | $19.1M | 1,299 | Developer of molecular diagnostic testing solutions | |
| fluidigm.com | 1999 | San Francisco, United States | $40.53M | 205 | Instruments for life sciences research and applications are developed. | |
| completegenomics.com | 2006 | San Jose, United States | $124.99M | 70 | DNA sequencing platform for human genome analysis is developed. | |
| genapsys.com | 2010 | Redwood, United States | $313.03M | 60 | Provider of DNA sequencing technologies for applied genomic testing and medical sequencing | |
| stillatechnologies.com | 2013 | Villejuif, France | $53.11M | – | Digital PCR solutions for research are developed and analyzed. | |
| stratosgenomics.com | 2007 | Seattle, United States | $62.89M | 64 | Nanopore-based single molecule sequencers are developed using SBX technology. | |
| nabsys.com | 2004 | Providence, United States | $144.3M | 44 | Developer of tools to map whole genome sequencing | |
| quantalife.com | 2008 | Pleasanton, United States | $28.71M | – | Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease. | |
| iontorrent.com | 2007 | Guilford, United States | $37.06M | – | Next-generation sequencing is enabled by semiconductor technology for DNA analysis. |
Detailed competitors of Helixis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Helixis
Complete news archive for Helixis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Helixis
10 companies that operate in the same segment as Helixis (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Helixis
Helixis was founded in 2007.
Helixis is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Helixis is a funded company, having raised a total of $17.33M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Aug 2007.
Helixis was established in 2007 as a spin-out from Caltech, operating in the molecular diagnostics sector. Nucleic-acid analysis instruments were developed for research and clinical uses within the biotechnology field. The companys activities centered on creating diagnostic products. Operations were conducted in Carlsbad, United States. Acquisition by Illumina occurred in July 2010 for 105 million.
Helixis's top competitors include Cepheid, Stilla Technologies and Complete Genomics.
Helixis has 4 investors. Key investors include Illumina, Domain Associates, Okapi Venture Capital, and Advanced Technology Ventures.
Yes. Helixis was acquired by Illumina in July 2010.